Citation: | WANG Danwei, ZHANG Fangfang, JIN Liang, WU Jie. Inhibition of miR-802 on insulin secretion by targeting Hnf1B[J]. Journal of China Pharmaceutical University, 2020, 51(1): 99-106. DOI: 10.11665/j.issn.1000-5048.20200115 |
[1] |
Shaw JE,Sicree RA,Zimmet PZ.Global estimates of the prevalence of diabetes for 2010 and 2030[J].Diabetes Res Clin Pract,2010,87(1):4-14.
|
[2] |
Du T,Chen J,Shen X.Research advances in susceptibility genes of non-alcoholic fatty liver disease and its association with type 2 diabetes[J].J China Pharm Univ(中国药科大学学报),2018,49(5):537-544.
|
[3] |
Wu Y, Tang TT, Zhu QH, et al. Mechanisms of miR-29a in migration and invasion of breast cancer MCF-7 cells in vitro[J].J China Pharm Univ(中国药科大学学报),2018,49(3):348-353.
|
[4] |
Chen X, Ba Y, Ma LJ, et al. Characterization of microRNAs in serum:a novel class of biomarkers for diagnosis of cancer and other diseases[J].Cell Res,2008,18(10):997-1006.
|
[5] |
van de Bunt M,Gaulton KJ,Parts L,et al.The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis[J].PLoS One,2013,8(1):e55272.
|
[6] |
Esguerra JL,Bolmeson C,Cilio CM,et al.Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat[J].PLoS One,2011,6(4):e18613.doi: 10.1371/journal.pone.0018613.
|
[7] |
El Ouaamari A,Baroukh N,Martens GA,et al.MiR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells[J].Diabetes,2008,57(10):2708-2717.
|
[8] |
Tang XQ,Muniappan L,Tang GL,et al.Identification of glucose-regulated miRNAs from pancreatic beta cells reveals a role for miR-30d in insulin transcription[J].RNA,2009,15(2):287-293.
|
[9] |
Sun LL,Jiang BG,Li WT,et al.MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression[J].Diabetes Res Clin Pract,2011,91(1):94-100.
|
[10] |
Sun D,Chen J,Wu W,et al.MiR-802 causes nephropathy by suppressing NF-κB-repressing factor in obese mice and human[J].J Cell Mol Med,2019,23(4):2863-2871.
|
[11] |
Kornfeld JW,Baitzel C,Könner AC,et al.Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b[J].Nature,2013,494(7435):111-115.
|
[12] |
Zhang FF,Liu Y,Jin L.Mechanism of lncRNA-Pluto on promoting insulin biosynthesis and secretion[J].J China Pharm Univ(中国药科大学学报),2019,50(4):481-489.
|
[13] |
Wang L,Coffinier C,Thomas MK,et al.Selective deletion of the Hnf1beta(MODY5)gene in beta-cells leads to altered gene expression and defective insulin release[J].Endocrinology,2004,145(8):3941-3949.
|
[14] |
El-Khairi R,Vallier L.The role of hepatocyte nuclear factor 1β in disease and development[J].Diabetes Obes Metab,2016,18(Suppl 1):23-32.
|
[15] |
Su SH,Wu GY,Cheng XD,et al.Oleanolic acid attenuates PCBs-induced adiposity and insulin resistance via HNF1b-mediated regulation of redox and PPAR signaling[J].Free Radic Biol Med,2018,124:122-134.
|
[16] |
Clissold RL,Hamilton AJ,Hattersley AT,et al.HNF1B-associated renal and extra-renal disease-an expanding clinical spectrum[J].Nat Rev Nephrol,2015,11(2):102-112.
|
[17] |
Horikawa Y, Iwasaki N, Hara M, et al. Mutation in hepatocyte nuclear factor-1 beta gene(TCF2)associated with MODY[J].Nat Genet,1997,17(4):384-385.
|
[18] |
Bellanné-Chantelot C,Chauveau D,Gautier JF,et al.Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations[J].Ann Intern Med,2004,140(7):510-517.
|
[19] |
Haldorsen IS,Vesterhus M,Raeder H,et al.Lack of pancreatic body and tail in HNF1B mutation carriers[J].Diabet Med,2008,25(7):782-787.
|
[20] |
Brackenridge A,Pearson ER,Shojaee-Moradie F,et al.Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and-1alpha mutations[J].Diabetes,2006,55(2):405-411.
|
[21] |
Cebola I,Rodríguez-Seguí SA,Cho CH,et al.TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors[J].Nat Cell Biol,2015,17(5):615-626.
|
[22] |
Panneerselvam A,Kannan A,Mariajoseph-Antony LF,et al.PAX proteins and their role in pancreas[J].Diabetes Res Clin Pract,2019,155:107792.
|
[1] | LIN Lin, QI Xiaodong, LI Yongsu, YANG Yubo, YANG Minghua, CHEN Yi, KONG Lingyi, WANG Li. Identification of involatile chemical components from Moutai-flavored distiller’s grains[J]. Journal of China Pharmaceutical University, 2023, 54(4): 461-467. DOI: 10.11665/j.issn.1000-5048.2023040402 |
[2] | ZHANG Jing, LI Lun, ZHANG Mei, HU Xiaolong, WANG Hao. Research progress in chemical constituent and pharmacological activity of Punica granatum L.[J]. Journal of China Pharmaceutical University, 2023, 54(4): 421-430. DOI: 10.11665/j.issn.1000-5048.2023032101 |
[3] | SUN Biao, AO Yunlin, WANG Dezhi, WANG Junya, YE Wencai, ZHANG Xiaoqi. Chemical constituents of petroleum ether extract from the stems and leaves of Humulus scandens[J]. Journal of China Pharmaceutical University, 2022, 53(2): 178-184. DOI: 10.11665/j.issn.1000-5048.20220207 |
[4] | YANG Xiaojun, AI Fengfeng, LIN Junbing, TANG Jiangjiang. Chemical constituents extracted from Dictamnus dasycarpus and their α-glucosidase inhibitory activity[J]. Journal of China Pharmaceutical University, 2019, 50(1): 41-45. DOI: 10.11665/j.issn.1000-5048.20190105 |
[5] | Pham Thi Anh, LI Junyan, ZHANG Baobao, WANG Hao. Chemical constituents from the n-butanol portions of the fruits of Eucalyptus globulus[J]. Journal of China Pharmaceutical University, 2018, 49(4): 422-426. DOI: 10.11665/j.issn.1000-5048.20180406 |
[6] | MA Lin, ZHANG Yaozhou, DANG Jun. Chemical constituents from water extract of Armillaria luteo-virens[J]. Journal of China Pharmaceutical University, 2016, 47(3): 291-293. DOI: 10.11665/j.issn.1000-5048.20160307 |
[7] | YIN Minmin, YIN Zhiqi, ZHANG Jian, WANG Lei, YE Wencai. Chemical constituents from ethyl acetate extract of Cynanchum otophyllum Schneid.[J]. Journal of China Pharmaceutical University, 2013, 44(3): 213-218. DOI: 10.11665/j.issn.1000-5048.20130305 |
[8] | SUN Jing, YIN Zhi-qi, ZHANG Qing-wen, YE Wen-cai, WANG Yi-ta, ZHAO Shou-xun. Chemical constituents from ethyl acetate extract of Ganoderma lucidum[J]. Journal of China Pharmaceutical University, 2011, 42(3): 220-222. |
[9] | Chemical constituents from n-butanol extract of the stems of Lonicera japonica[J]. Journal of China Pharmaceutical University, 2010, 41(4): 333-336. |
[10] | Hypoglycemic Effects of Extracts and Constituents from Euonymus alatus[J]. Journal of China Pharmaceutical University, 2003, (2): 32-35. |